Page 2 - Robert Steinbrook News Today

Amid a massive recall in 2021, Philips raced to overcome troubling questions about its replacement machines as customers waited for help.

Purveyors on coupon sites like Groupon are marketing weight loss programs that include compounded semaglutide and tirzepatide.

Philips argued in court that its U.S. subsidiary should be responsible for damages caused by its CPAP machines and ventilators. Patients’ attorneys say safety decisions were made at the Dutch company’s highest levels.

Philips says its US subsidiary should cover CPAP damages, but attorneys argue safety calls were made at the company’s highest levels.

Opioid treatment advocates are closely watching the DEA as its telehealth rulemaking process forges ahead, and some are raising concerns.

The changes in coverage for millions of Americans, already underway, could derail treatment plans for the most vulnerable patients being treated for opioid use disorder, providers and public health experts told POLITICO.

From today through the end of September, the FDA has scheduled seven meetings of its expert panels, none of which will be in person.

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

The share of money heading towards lobbying activities on Capitol Hill is increasingly coming from healthcare companies. The ...

The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels was $1.5 billion.